Generative Data Intelligence

Tag: Alzheimer’s disease

The First Complete Brain Map of an Insect May Reveal Secrets for Better AI

Breakthroughs don’t often happen in neuroscience, but we just had one. In a tour-de-force, an international team released the full brain connectivity map of...

Human Mini-Brains Grafted Into Injured Rats Restored Their Sight

Nearly a decade ago, mini-brains shot onto the neuroscience scene with a hefty promise: understanding the developing brain and restoring injured brains.Known as brain...

Stimulating the brain at 40 Hz to treat Alzheimer’s disease

What if exposure to 40 Hz light and sound could promote a healthier brain? That’s the...

GPT-3’s Next Mark: Diagnosing Alzheimer’s Through Speech

There’s one deceptively simple early sign of Alzheimer’s not often talked about: a subtle change in speech patterns.Increased hesitation. Grammatical mistakes. Forgetting the meaning...

Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety in Alzheimer’s Disease

TORONTO–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next...

What Causes Alzheimer’s? Scientists Are Rethinking the Answer.

IntroductionIt’s often subtle at first. A lost phone. A forgotten word. A missed appointment. By the time a person walks into a doctor’s office,...

Study found link between Periodontitis and Alzheimer’s Disease

Alzheimer’s disease is a neuropathological disorder causing memory loss and cognitive impairment hence degeneration of brain tissue due to inflammation and other risk factors....

6 Healthtech Startups From Singapore to Watch in 2022

The healthtech sector has risen consistently over the past years, but the COVID-19 pandemic undeniably accelerated that growth, acting as a catalyst for investment in an already burgeoning sector. In

The post 6 Healthtech Startups From Singapore to Watch in 2022 appeared first on Fintech Singapore.

Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-allotment Option for Gross Proceeds of $14.4 Million

TAMPA, Fla.–(BUSINESS WIRE)–$AMEX #ADDF—Alzamend Neuro, Inc. (“Alzamend”), a preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases...

The Latest Oculus Launch Pad Beneficiaries Showcase a Diverse VR Collection

Facebook has plowed a lot of money into virtual reality (VR) content creation, helping fund Oculus platform exclusives like Asgard’s Wrath. But it...

A Backdoor Lets the Immune System Monitor the Brain

A hundred years ago, the Japanese scientist Y. Shirai published a mysterious finding: When Shirai transplanted tumor tissue into a mouse’s body, the...

Pico Interactive partners with REACT Neuro to measure brain health via wireless Virtual Reality headsets

In Virtual Reality News April 28, 2021 – Pico Interactive, a provider of virtual reality (VR) and enterprise solutions, has announced that its hardware...

Latest Intelligence

spot_img
spot_img
spot_img